About
Direct Oral Anticoagulant
Areas of Focus
Categories
Small Molecule PharmaceuticalRussia
Clinical Trials (3)
View allTotal Trials
3
As Lead Sponsor
3
As Collaborator
0
Total Enrollment
663
By Phase
PHASE3: 1PHASE2: 1PHASE1: 1
By Status
COMPLETED: 2UNKNOWN: 1
Clinical Trials Pipeline3 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2016
2017
2018
2019
2020
2021
2022
2023
Today
Hover over trial bars to see details
Recent Trials
NCT05185804Lead Sponsor
Clinical Trial of Dimolegin (DD217) in Prevention of Thrombotic Complications in Patients With COVID-19
PHASE3Completed
399 participants
Started: Feb 8, 2021 · Completed: Oct 29, 2021
NCT05189002Lead Sponsor
A Study to Evaluate Dimolegin in Prevention of Thromboembolic Complications During Knee Replacement
PHASE2Unknown
240 participants
Started: May 31, 2019 · Completed: Dec 31, 2022
NCT05181241Lead Sponsor
A Study of Pharmacokinetics, Safety and Tolerability of Dimolegin (DD217)
PHASE1Completed
24 participants
Started: Jan 25, 2017 · Completed: Apr 25, 2018
Locations (1)
Headquarters
Moscow, Russia
Map
Loading map...